Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 354793-04-7 | MDL No. : | MFCD11973607 |
Formula : | C10H8N2O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NWNGKOXONKYINR-UHFFFAOYSA-N |
M.W : | 220.18 g/mol | Pubchem ID : | 23847563 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.1 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 56.47 |
TPSA : | 92.02 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.43 cm/s |
Log Po/w (iLOGP) : | 1.06 |
Log Po/w (XLOGP3) : | 0.3 |
Log Po/w (WLOGP) : | 0.0 |
Log Po/w (MLOGP) : | 0.58 |
Log Po/w (SILICOS-IT) : | 2.05 |
Consensus Log Po/w : | 0.8 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.72 |
Solubility : | 4.15 mg/ml ; 0.0189 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.79 |
Solubility : | 3.53 mg/ml ; 0.016 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.23 |
Solubility : | 0.131 mg/ml ; 0.000593 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.91 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | for 88 h; Reflux | Condensation of methyl 3 ,4-diaminobenzoate with diethyl oxalate (8.0 equivalents) in toluene (10 volumes) was carried out at reflux for 88 hours. After complete conversion, the mixture was concentrated to a residue which was washed with MTBE. After drying intermediate 184 was obtained in 90percent yield. |
90% | for 88 h; Reflux | Condensation of methyl 3,4-diaminobenzoate with diethyl oxalate (8.0 equivalents) in toluene (10 volumes) was carried out at reflux for 88 hours. After complete conversion, the mixture was concentrated to a residue which was washed with methyl tert-butyl ether. After drying intermediate 25 was obtained in 90percent yield. |
[ 3814-10-6 ]
Methyl 4-(phenylcarbamoyl)benzoate
Similarity: 0.79
[ 301533-59-5 ]
Methyl 4-butyramido-3-methylbenzoate
Similarity: 0.78
[ 4093-28-1 ]
Methyl 4-acetamido-2-hydroxybenzoate
Similarity: 0.77
[ 3734-33-6 ]
N-Benzyl-2-((2,6-dimethylphenyl)amino)-N,N-diethyl-2-oxoethanaminium benzoate
Similarity: 0.77
[ 3814-10-6 ]
Methyl 4-(phenylcarbamoyl)benzoate
Similarity: 0.79
[ 301533-59-5 ]
Methyl 4-butyramido-3-methylbenzoate
Similarity: 0.78
[ 4093-28-1 ]
Methyl 4-acetamido-2-hydroxybenzoate
Similarity: 0.77
[ 66315-16-0 ]
Methyl 3-amino-4-(methylamino)benzoate
Similarity: 0.77
[ 597562-39-5 ]
Methyl 4-amino-3-(butylamino)benzoate
Similarity: 0.76
[ 4784-02-5 ]
6,7-Dimethoxyquinoxaline-2,3(1H,4H)-dione
Similarity: 0.67
[ 106595-91-9 ]
4-Benzyl-1,3-dihydroquinoxalin-2-one
Similarity: 0.64
[ 6924-71-6 ]
Methyl quinoxaline-5-carboxylate
Similarity: 0.59
[ 1910-90-3 ]
6-Bromoquinoxaline-2,3(1H,4H)-dione
Similarity: 0.58